Company: LCTX
Filing Date: 2025-08-15
Form Type: S-8
Source: 0000950170-25-109396
Chunk: 3

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-08-15
Form: S-8
Chunk 3
---
 Cell Therapeutics, Inc., constitutes and appoints Brian M. Culley and Jill Ann Howe, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and on his or her behalf and in his or her name, place and stead, in any and all capacities, to sign, execute and file this Registration Statement under the Securities Act of 1933, as amended, and any one or more amendments to any part of this Registration Statement, including any post- effective amendments, or appendices or supplements that may be required to be filed under the Securities Act of 1933, as amended, to keep such Registration Statement effective or to terminate its effectiveness, with all exhibits and any and all documents required to be filed with respect thereto, with the Securities and Exchange Commission or any regulatory authority, granting unto such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises in order to effectuate the same, as fully to all intents and purposes as he or she himself or herself might or could do, if personally present, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done. Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature             
 /s/ Brian M. Culley   |     | Title                                       
 Chief Executive Officer and Director        |     | Date            
 August 15, 2025 |
|:----------------------|:----|:--------------------------------------------|:----|:----------------|
| Brian M. Culley       |     | -Principal Executive Officer                |     |                 |
| /s/ Jill Ann Howe     |     | Chief Financial Officer                     |     | August 15, 2025 |
| Jill Ann Howe         |     | -Principal Financial and Accounting Officer |     |                 |
| /s/ Michael H. Mulroy |     | Chair of the Board                          |     | August 15, 2025 |
| Michael H. Mulroy     |     |                                             |     |                 |
| /s/ Dipti Amin        |     | Director                                    |     | August 15, 2025 |
| Dipti Amin            |     |                                             |